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Abstract
Background: Non-steroidal anti-inflammatory drugs (NSAID) are commonly used in the
treatment of tendinopathies such as tendonitis and tendinosis. Despite this, little is known of their
direct actions on tendon-derived cells. As NSAIDs have been shown to delay healing in a number
of mesenchymal tissues we have investigated the direct effects of indomethacin on the proliferation
of tendon-derived cells.
Results and Discussion: The results obtained were dependent on both the type of cells used and
the method of measurement. When measured using the Alamar blue assay, a common method for
the measurement of cell proliferation and viability, no effect of indomethacin was seen regardless
of cell source. It is likely that this lack of effect was due to a paucity of mitochondrial enzymes in
tendon cells.
However, when cell number was assessed using the methylene blue assay, which is a simple nuclear
staining technique, an Indomethacin-induced inhibition of proliferation was seen in primary cells but
not in secondary subcultures.
Conclusion: These results suggest that firstly, care must be taken when deciding on methodology
used to investigate tendon-derived cells as these cells have a quite different metabolism to other
mesenchymal derive cells. Secondly, Indomethacin can inhibit the proliferation of primary tendon
derived cells and that secondary subculture selects for a population of cells that is unresponsive to
this drug.
Introduction
Non-steroidal inflammatory drugs (NSAIDs) are com-
monly used for the treatment of a number of muscu-
loskeletal sports injuries including the inflammation of
tendons and ligaments. A number of studies have how-
ever, suggested that NSAIDs may delay soft tissue healing
although the exact mechanism of action for this is
unknown [1-4]. Some in vitro investigations on the effects
of NSAIDs on tenocytes have been performed [5-9]. How-
ever, they have used limited dose-ranges of NSAIDs and
subcultures of tenocytes. We have previously argued that
sub-culturing tenocytes selects for rapidly proliferating
population of cells and is not necessarily representative of
the situation found in vivo where the majority of cells are
non-proliferative [10,11]. In contrast, primary cultures of
tenocytes contain all of the cells originally present in the
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would therefore seem likely to be a more realistic model
of tendon metabolism. We have therefore investigated the
effects of NSAIDs on both primary tenocytes and second-
ary and tertiary subcultures of the cells.
Methods
Isolation and culture of tendon derived cells: Tendon
derived cells (TDC) were obtained from the tail tendons
of 200 g male Wistar rats. Rat-tail tendons were chosen
because they can be obtained in sufficient quantities to
allow the extensive use of primary cells. Although they are
not completely relevant to human pathologies they show
similar age-related changes in their biomechanical prop-
erties to other tendons and in this laboratory rat tail TDC
behave similarly to cells derived from other tendons;
human and rat. The rats were maintained according to UK
home office regulations and killed by a schedule 1
method. The tendons were dissected free from the tails
and the TDC freed from the tendons by digesting for 18 h
at 37°C in 1 mg/ml crude collagenase in culture medium.
After digestion the cells were washed, resuspended and
viable cells determined.
The cells were then used immediately in primary high-
density cultures or plated out for secondary cultures.
Primary or secondary cells were plated out in 24 well
plates at a density of 10,000 cells per well in DMEM con-
taining 10% FCS, penicillin/streptomycin and glutamine.
The cells were treated with indomethacin (0.1 nm – 100
uM) for 6 days. The cultures were then stopped and cell
number determined by either Alamar blue assay, methyl-
ene blue assay or by direct counting using a Guava PCS.
Alamar blue assay
At the end of the culture period 50 μL of Alamar blue was
added to the cultures, which were then incubated at 37°C
for further four hours. Cell number was then determined
by analysing the supernatants spectrophotometrically at
570 and 600 nm.
Methylene blue assay
The cells were fixed with cold ethanol and then washed
with borate buffer (pH 8.8, 20 mM). Cells were then
stained with methylene blue (1 mg/ml in borate buffer)
for 30 minutes after which they were washed three times
with borate buffer. The dye was then eluted with 1% HCl
in ethanol and cell number determined by measuring the
absorbance at 650 nm.
Guava PCS
The cells were diluted 1 in 10 in Guava Viacount reagent
(containing 7-amino-actinomycin D) and cell number
and viability determined using a guava personal cytome-
try system according to the manufacturer's instructions.
Data handling and statistical analyses: Data are presented
as group mean ± standard deviation. At least 3 replicates
of each experiment were performed, and the results pre-
sented in the figures are representative of these. For each
variable, effects across treatment groups were compared
with one-way analysis of variance (ANOVA). If the overall
difference was significant, multiple comparisons were per-
formed between groups using Tukey's test. Differences are
considered significant at a probability <0.05 on a two-
tailed test.
Results
Initial experiments studying the effects of indomethacin
on tendon derived cell proliferation were carried out
using the commonly used Alamar blue assay. However,
although on visual examination an effect was evident, no
effect was seen after analysis of the cell supernatants (Fig-
ure 1 & Figure 2).
We therefore adopted the methylene blue assay to deter-
mine tendon-derived cell numbers. Although this assay
has the disadvantage of detecting both live and dead cells
it is thoroughly reliable and accurate. Using this assay, it
was found that treating primary cells with indomethacin
lead to a dose related inhibition of cell proliferation.
However, rather unexpectedly the relationship was nega-
tive with the greatest inhibition being seen at 10 nM and
essentially no effect at 100 μM (Figure 3). In secondary
subcultures of tendon-derived cells, the cells became rela-
tively refractive to treatment with indomethacin showing
This graph shows the relationship between increasing Indomethacin concent ation and cell number of primary ten-don derived cells as me sured by A amar BlueFigur  1
This graph shows the relationship between increas-
ing Indomethacin concentration and cell number of 
primary tendon derived cells as measured by Alamar 
Blue.Page 2 of 7
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then by the third subculture a biphasic stimulation of pro-
liferation were seen with a maximum at 1–10 μM (data
not shown).
Because of the somewhat unexpected inhibition of prolif-
eration with low concentrations of Indomethacin, this
work was repeated using direct counts of cell number and
viability (as measured by 7-amino-actinomycin D
uptake). Although the concentration relationship was not
as linear as with the methylene blue assay, this too
showed a significant decrease in cell number at lower con-
centrations of indomethacin whereas treatment with high
concentrations had essentially no effect (Figure 5). Also
the results with secondary sub culture of tenocytes were
similar to methylene blue with no effect of indomethacin
on proliferation. We did not repeat this with tertiary sub-
culture of tenocytes.
This graph shows the relationship between increasing Indomethacin concent ation and cell number of secondary tendon derived cells as measured y Alamar BlueFigur  2
This graph shows the relationship between increas-
ing Indomethacin concentration and cell number of 
secondary tendon derived cells as measured by 
Alamar Blue.
This graph shows the relationship between increasing Indomethacin concent ation and cell number of primary ten-don derived cells as me sured by M hyl  BlueFigur  3
This graph shows the relationship between increas-
ing Indomethacin concentration and cell number of 
primary tendon derived cells as measured by Methyl-
ene Blue.
This graph shows the relationship between increasing Indomethacin concent ation and cell number of Secondary tendon derived cells as measured y Methylene BlueFigur  4
This graph shows the relationship between increas-
ing Indomethacin concentration and cell number of 
Secondary tendon derived cells as measured by 
Methylene Blue.
This graph shows the relationship between increasing Indomethacin concent ation and cell number of primary ten-don derived cells as me sured by direct cell c unting me h-odsFigur  5
This graph shows the relationship between increas-
ing Indomethacin concentration and cell number of 
primary tendon derived cells as measured by direct 
cell counting methods.Page 3 of 7
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number using Alamar Blue was somewhat unexpected as
this is a well established method of determining cell
number and is used with a wide variety of cell types. An
experiment relating cell number and absorption revealed
this to be a cell dependent problem as Methylene blue
staining gave rise to a strong cell-dependent increase in
staining whereas the response using Alamar blue was
essentially flat with very little response (Figure 6). In com-
parison, mesenchymal stem cells produce very similar
curves regardless of whether they are stained with Methyl-
ene blue or Alamar blue (data not shown). To try and
determine the cause of this we stained the cells with 3-
(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (commonly known as MTT) which is metabolized
from yellow MTT to an insoluble purple formazan by a
similar mechanism to Alamar blue. It was found that
whereas Methylene blue stained all of the cells evenly
throughout the cultures, it was evident that there were 2
populations of cells in the tenocyte cultures, one staining
strongly with MTT and the other barely staining at all (Fig-
ure 7).
Discussion
Tendon injuries produce considerable morbidity, and the
disability that they cause may last for several months
despite what is considered appropriate management [12].
The basic cell biology of tendons is still not fully under-
stood, and the management of tendon injury poses a con-
siderable challenge for clinicians [12]. Even though
histological studies have shown absence of acute inflam-
matory cells in chronic tendonitis, NSAIDs are used com-
monly for managing tendon injuries [13-16]. Clinical
studies indicate that they decrease the pain, tenderness
and stiffness associated with acute soft tissue injury 3(4).
The effect of NSAIDs on tenocytes however, remains
debatable. Studies with NSAIDs have shown both benefi-
cial [7,17] and harmful effects on tenocytes [6,8]. As the
tenocyte is the major cell type in tendons and is responsi-
ble for the production and maintenance of extra cellular
matrix, we investigated the effect of Indomethacin, com-
monly used NSAIDs for tendon injuries on tenocyte pro-
liferation. Of particular interest to our study was the effect
of primary and sub culture of tenocytes and different cell
counting methods for tenocytes.
Tenocyte culture provides a uniform, controlled environ-
ment in which to study the in vitro effects of Indometh-
acin, with limitation of other uncontrolled variables and
avoidance of the confounding influences that are present
in animal models [18]. The results of our in vitro experi-
ments showed that Indomethacin had a dose related effect
on tenocyte proliferation. Indomethacin reduced the
number of human tenocyte cells at a dose between 0.1 nM
to 100 nM. However at higher doses it did not inhibit ten-
ocyte proliferation. This is in contrast to some studies
showing inhibition of tenocytes with therapeutic doses of
Indomethacin and hence producing a negative effect on
healing tendons [6,8]. Other studies have shown benefi-
cial effect on tenocyte healing by increasing the tensile
strength to failure [5,7,17]. This is due to increased matu-
ration of collagen fibrils during healing. However it is still
debatable whether this beneficial effect is due to prolifer-
ation of tenocytes or increased production of collagen and
maturation. Our study indicating that Indomethacin in
therapeutic doses did not inhibit tenocyte proliferation
has clinical relevance. This would be beneficial in tendon
healing and repair as tenocyte is the major cell type in ten-
dons and is responsible for the production and mainte-
nance of extracellular matrix.
The negative dose response effect of Indomethacin on ten-
don derived cell proliferation remains a conundrum and
we have no explanation to this. It should however be
noted that serum levels of Indomethacin generally reach a
peak of 1–10 μg/ml after administration and due to the
poor blood supply in tendons, it is likely that tenocytes
are exposed to concentrations even lower than this. These
concentrations are well within the range at which the
above effects were seen in vitro but did not go any way
towards explaining the lack of effect at higher concentra-
tions.
Dissimilar culture conditions as in vivo or in vitro, differ-
ing species and even changes in cell culture conditions of
the same species have shown different tenocyte behaviour
[5-7,17-20]. It can thus be stated that interaction between
Comparison of absorbances of Alamar blue and methylene blue obtained after culture of rat tail tendon deriv d cells at varying co centrati ns for 2 and 7 d ysFigure 6
Comparison of absorbances of Alamar blue and 
methylene blue obtained after culture of rat tail ten-
don derived cells at varying concentrations for 2 and 
7 days. Data points are mean of 3 wells. Results were signifi-
cant between cell numbers seeded for both dyes at both 
time points using ANOVA.Page 4 of 7
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leading to opposing results. It has been previously argued
that sub culture of mesenchymal cells do not reciprocate
in vivo results [11]. However this effect has not been stud-
ied or documented before, with tenocytes. We considered
this as an important area of investigation and looked at
role of culture conditions on effect of Indomethacin on
tenocytes. We noted that sub culture of cells did not show
similar results as primary tenocytes. The dose dependent
effect of Indomethacin was only seen on primary teno-
cytes and sub culture of cells did not show this effect. Pre-
vious studies have shown Indomethacin to cause both
inhibition and proliferation of tenocytes in in vitro stud-
ies [6,10,14,17]. However these studies do not clearly
indicate if only primary or subcultures of cells were used.
Also it has not been mentioned previously if such effect
was seen. We postulate that this effect seen in our study
may be due to the selection of a highly proliferative pop-
ulation of tenocytes that is present in the primary digest
only at low levels which subsequently overgrow the
slower growing cells in later passages. We consider this an
important finding, as studies, which have used sub culture
of cells, need to be reviewed with some caution.
Various cell-counting methods are used to measure teno-
cyte proliferation. Initial experiments studying the effects
of Indomethacin on tendon derived cell proliferation
were carried out using the commonly used Alamar blue
assay. However, although on visual examination an effect
was evident, no effect was seen after analysis of the cell
supernatants. This conundrum was subsequently
explained by the finding that tendons appear to contain 2
subpopulations of cells; one subpopulation with appar-
ently normal metabolic activity and a second subpopula-
tion of cells with low levels of mitochondrial enzymes
and subsequently a low oxidative metabolism. As the
Alamar blue assay is dependent on mitochondrial enzyme
activity for the reduction of the dye resazurin to resorufin,
in cells without these enzymes, no effect was seen. This
was confirmed by the use of MTT which is metabolized by
the same enzymes to produce a purple product and it was
clearly demonstrated that 2 subpopulations of cells exist;
one staining intensely indicating a high metabolic activity
and one stained relatively mildly indicating a low meta-
bolic activity. This is entirely consistent current knowl-
edge regarding the metabolic activity of tenocytes and
tenoblasts. Tenoblasts are known to contain relatively
high numbers of mitochondria and tenocytes very few
suggesting comparatively high and low oxidative metabo-
lism respectively [21]. This would in turn that the
response seen in primary cells is due to the presence of
mature tenocytes in the cultures which would have been
lost on subsequent passage. As tenocytes are thought to be
non-proliferative it is obviously unlikely that this is due to
an inhibition of proliferation. One possibility is a toxic
effect on specific to tenocytes but not tenoblasts however,
we saw no evidence of excessive cell death in these cul-
tures. Another possibility is that the tenocytes play some
Staining of tendon derived cells with A, methylene blue or B, MTTFigure 7
Staining of tendon derived cells with A, methylene blue or B, MTT. Monolayer cultures of rat tail tendon cells were 
grown to confluence, then stained with these substances as described in materials and methods. Following staining cultures 
were photographed. Staining with methylene blue produces even staining whereas staining with MTT produces patchy results 
with some cells staining strongly and others barely staining at all.
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proliferative tenoblasts as is thought to be the case for
osteocytes and osteoblasts [22]. This must however
remain speculative until further evidence is available.
One consequence of these data is that investigations using
Alamar blue or MTT to assess tenocytes numbers should
be interpreted with some caution. We therefore adopted
the methylene blue assay to determine tendon-derived
cell numbers. Although this assay has the disadvantage of
detecting both live and dead cells it is thoroughly reliable
and accurate. Using this assay, it was found that treating
primary cells with indomethacin led to a dose related
inhibition of cell proliferation. In secondary subcultures
of tendon-derived cells, the cells became relatively refrac-
tive to treatment with indomethacin showing no signifi-
cant effect at any concentration (Figure 4). Because of the
somewhat unexpected inhibition of proliferation with
low concentrations of Indomethacin, this work was
repeated using direct counts of cell number and viability
(as measured by 7-amino-actinomycin D uptake).
Although the concentration relationship was not as good
as with the methylene blue assay, this too showed a signif-
icant decrease in cell number at lower concentrations of
indomethacin whereas treatment with high concentra-
tions had essentially no effect (Figure 5).
The cause of this rather unexpected dose/effect relation-
ship is at present unclear. Indomethacin is thought to act
principally by the modulation of arachidonic acid metab-
olism via the cyclooxygenase and lipoxygenase pathways
thus blocking the production of prostaglandins and
HETEs/leukotrienes respectively. The relationship is how-
ever not simple as indomethacin has been shown to stim-
ulate [23] and inhibit [24] the production of lipoxygenase
metabolites. This differential effect is likely to be both tis-
sue and concentration dependent and is further compli-
cated by the possibility that blocking one pathway is likely
to shunt metabolites down the other. No drugs are 100%
specific for any one particular mechanism of action and
indomethacin is no exception giving rise to a number of
effects unrelated to cyclooxygenase [25]. Lastly, endocan-
nabinoids are now known to have a number of peripheral
effects on connective tissue [26] and preliminary investi-
gations in this laboratory indicate that this is also the case
in tendons and ligaments. In relation to this, indometh-
acin has been shown to inhibit the enzyme fatty acid
amide hydrolase (FAAH), which metabolizes endocan-
nabinoids [27]; inhibition of FAAH would therefore result
in the build of levels of endocannabinoids. The situation
is therefore highly complex and is unlikely to be
unraveled until further insights into the relative roles of
prostaglandins, leukotrienes and endocannabinoids in
tendons are obtained.
It should be stressed that in this study we have only inves-
tigated the effects of indomethacin on cell proliferation
and therefore no firm conclusions can be made regarding
the effects of indomethacin on other metabolic processes.
There have been few studies on tendon cells monitoring
both proliferation and collagen accumulation, however,
we have found that collagen accumulation in tendon cells
normally parallels cell number and that specific levels of
collagen synthesis remain largely unchanged [28-31]. This
would suggest that indomethacin would probably pro-
duce similar effects on matrix protein synthesis to those
described above, although this obviously requires confir-
mation.
Conclusion
In conclusion, these data show that primary tenocytes
respond to Indomethacin differently compared to second-
ary and tertiary subcultures. This may be due to the selec-
tion of a highly proliferative population of tenocytes that
is present in the primary digest only at low levels which
subsequently overgrows the slower growing cells in later
passages. This would suggest that where possible in vitro
investigations into tenocyte metabolism should preferen-
tially be performed using primary cells and that results
obtained using subcultures should be viewed with some
caution.
Furthermore we have shown that because of their lower
metabolic rate tendon derived cells cannot sufficiently
metabolise Resazurin, the dye used in the Alamar blue
assay. Because of this we would suggest that this essay is
not appropriate studying proliferation in tendon derived
cells and that an alternative, such as the methylene blue
assay, should be used.
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